214370 — Caregen Co Balance Sheet
0.000.00%
- KR₩1tn
- KR₩1tn
- KR₩83bn
- 56
- 18
- 90
- 58
Annual balance sheet for Caregen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 127,633 | 136,268 | 140,479 | 132,724 | 44,262 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,815 | 6,154 | 7,638 | 14,184 | 33,320 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 140,561 | 149,329 | 158,933 | 166,427 | 96,406 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 59,962 | 62,111 | 60,407 | 63,996 | 125,592 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 216,556 | 226,760 | 234,070 | 247,277 | 240,697 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,592 | 9,850 | 10,491 | 11,314 | 8,066 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,396 | 17,042 | 18,092 | 19,978 | 17,719 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 205,160 | 209,718 | 215,978 | 227,299 | 222,978 |
Total Liabilities & Shareholders' Equity | 216,556 | 226,760 | 234,070 | 247,277 | 240,697 |
Total Common Shares Outstanding |